BODE Index for COPD Survival

ورودی‌های بالینی بیمار

حداقل ۱۰ — حداکثر ۱۵۰ • واحد: %

حداقل ۰ — حداکثر ۱۰۰۰ • واحد: meters

حداقل ۱۰ — حداکثر ۵۰ • واحد: kg/m²

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
bode index score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Quartile 1 (Low Risk)0–2
  • Quartile 2 (Moderate Risk)3–4
  • Quartile 3 (High Risk)5–6
  • Quartile 4 (Very High Risk)7–10
Direct Clinical Answer

The BODE Index for COPD Survival calculates predicting survival and mortality risk in patients with Chronic Obstructive Pulmonary Disease (COPD). Key inputs include fev1 percent predicted. Scores guide determining appropriate admission level (floor versus ICU), tailoring antimicrobial therapy, and ventilatory support. Routine clinical application promotes standardized evidence-based patient management.

Clinical Guidelines & Evidence

Predicts survival and mortality risk in patients with Chronic Obstructive Pulmonary Disease (COPD). The BODE Index (Body-Mass Index, Obstruction, Dyspnea, Exercise) is a multidimensional grading system that better predicts survival than FEV1 alone.

Clinical Indication

The BODE Index for COPD Survival is indicated for bedside clinical practice to support Predicts survival and mortality risk in patients with Chronic Obstructive Pulmonary Disease (COPD). The BODE Index (Body-Mass Index, Obstruction, Dyspnea, Exercise) is a multidimensional grading system that better predicts survival than FEV1 alone.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with community-acquired pneumonia, COPD exacerbations, acute asthma, pulmonary embolism, or acute respiratory distress. Clinical application is indicated across Respiratory care units, emergency pulmonary triage, sleep clinics, and medical floors.

Limitations & Contraindications

Peripheral pulse oximetry loses reliability in hypoperfusion, severe vasoconstriction, methemoglobinemia, or carboxyhemoglobinemia.

Clinical Pearls & Action Plan

Synchronous evaluation of arterial blood gas (PaO2/FiO2), mechanics of breathing, and clinical trajectory guides respiratory failure management. Guideline pearl: Does not guide specific treatment decisions but provides prognostic information.

Formula & Variables:

BODE Index = FEV1 score + 6MWD score + mMRC score + BMI score. Total score ranges from 0-10 points with higher scores indicating worse prognosis.

Input Parameters

NameTypeRequiredDescription
fev1_percent_predictedfloatYesFEV1 as percentage of predicted normal value based on age, sex, height, and ethnicity(%)
six_minute_walk_distanceintegerYesDistance walked in meters during standardized 6-minute walk test(meters)
mmrc_dyspnea_scalestringYesModified Medical Research Council Dyspnea Scale assessing functional disability due to breathlessness
body_mass_indexfloatYesBody mass index in kg/m²(kg/m²)

Score Interpretation & Guidance

RangeStageDescription
0–2Quartile 1 (Low Risk)BODE Index 0-2 points
3–4Quartile 2 (Moderate Risk)BODE Index 3-4 points
5–6Quartile 3 (High Risk)BODE Index 5-6 points
7–10Quartile 4 (Very High Risk)BODE Index 7-10 points

Evidence-Based References (EBM)

  • Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004 Mar 4;350(10):1005-12. doi: 10.1056/NEJMoa021322.DOI: 10.1056/NEJMoa021322
  • Ong KC, Earnest A, Lu SJ. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest. 2005 Dec;128(6):3810-6. doi: 10.1378/chest.128.6.3810.DOI: 10.1378/chest.128.6.3810
  • Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J. 2005 Oct;26(4):630-6. doi: 10.1183/09031936.05.00045505.DOI: 10.1183/09031936.05.00045505
  • Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009 Aug 29;374(9691):704-11. doi: 10.1016/S0140-6736(09)61301-5.DOI: 10.1016/S0140-6736(09)61301-5

Related calculators